| · The Grabody T platform: A Clinically Validated 4-1BB Bispecific Antibody Approach to Overcome Liver Toxicity
· Grabody T Exhibits TAA-Dependent 4-1BB Activation and Strong in vivo Efficacy · Promising Clinical Activity and Favourable Safety Profile Across the Grabody T Pipeline (Givastomig, Ragistomig, and YH32367) |
Archives: Agenda
From burden to breakthrough: next-gen CRO & Milo’s AI slash data entry, errors, and cost with no EHR integration required
- Enhancing patient recruitment and streamlining data capture using Milo’s AI-driven capabilities
- Integrating seamlessly into existing clinical research workflows for improved efficiency
- Maintaining compliance while driving efficiency in clinical research with Milo
- Simplifying processes and optimizing outcomes to reshape the future of clinical trials
Panel: Integrating sustainability strategies into your marketing & promotions
- Meeting the consumer demands for more sustainability
- Curating the right messaging
- Supporting the cause outside of production and manufacturing
The on-trade and off trade in the world of regulations
- Navigating the complexities of on-trade and off-trade regulations